You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 1
  • Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients

Article metrics

Article menu

Download PDFPDF

Oral Presentation
Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019030
Jan 2020042
Feb 2020053
Mar 2020043
Apr 2020053
May 2020053
Jun 2020091
Jul 2020040
Aug 2020032
Sep 2020060
Oct 2020032
Nov 2020045
Dec 2020023
Jan 20210143
Feb 2021022
Mar 2021074
Apr 2021071
May 2021021
Jul 2021065
Aug 2021031
Sep 2021033
Oct 20210316
Nov 20210214
Dec 2021040
Jan 2022051
Feb 2022012
Mar 2022031
Apr 2022002
May 20220513
Jun 2022062
Jul 20220112
Aug 20220142
Sep 2022068
Oct 2022054
Nov 2022053
Dec 2022070
Jan 2023041
Feb 2023030
Mar 2023041
Apr 2023041
May 2023014
Jun 2023010
Jul 2023027
Aug 2023022
Sep 2023079
Oct 2023021
Dec 20230153
Jan 2024070
Feb 2024091
Mar 2024020
Total0241147